Frank Navas

670 total citations
20 papers, 586 citations indexed

About

Frank Navas is a scholar working on Molecular Biology, Organic Chemistry and Cellular and Molecular Neuroscience. According to data from OpenAlex, Frank Navas has authored 20 papers receiving a total of 586 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 10 papers in Organic Chemistry and 10 papers in Cellular and Molecular Neuroscience. Recurrent topics in Frank Navas's work include Receptor Mechanisms and Signaling (9 papers), Neurotransmitter Receptor Influence on Behavior (5 papers) and Neuroscience and Neuropharmacology Research (4 papers). Frank Navas is often cited by papers focused on Receptor Mechanisms and Signaling (9 papers), Neurotransmitter Receptor Influence on Behavior (5 papers) and Neuroscience and Neuropharmacology Research (4 papers). Frank Navas collaborates with scholars based in United States, United Kingdom and Canada. Frank Navas's co-authors include Mark H. Norman, Greg C. Rigdon, Shawn P. Williams, Aaron B. Miller, Barrett R. Cooper, Dan Todd, Katrina L. Creech, Derek J. Parks, Kevin P. Madauss and David N. Deaton and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Medicinal Chemistry and The Journal of Organic Chemistry.

In The Last Decade

Frank Navas

19 papers receiving 570 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Frank Navas United States 14 253 209 206 112 91 20 586
Paul K. Spearing United States 9 208 0.8× 154 0.7× 242 1.2× 47 0.4× 32 0.4× 16 559
Xiao‐Hui Gu China 9 223 0.9× 311 1.5× 128 0.6× 96 0.9× 33 0.4× 13 606
Charles D. Thompson United States 18 463 1.8× 164 0.8× 203 1.0× 268 2.4× 94 1.0× 39 877
Emiliano Rosatelli Italy 10 170 0.7× 101 0.5× 265 1.3× 47 0.4× 35 0.4× 13 486
Feroze Ujjainwalla United States 16 299 1.2× 523 2.5× 75 0.4× 24 0.2× 108 1.2× 28 952
Lamees Hegazy United States 13 191 0.8× 128 0.6× 75 0.4× 20 0.2× 38 0.4× 28 421
Fumihiko Akahoshi Japan 15 265 1.0× 321 1.5× 249 1.2× 143 1.3× 23 0.3× 24 735
Kenneth A. Koeplinger United States 16 523 2.1× 117 0.6× 89 0.4× 183 1.6× 74 0.8× 23 733
Hea‐Young Park Choo South Korea 13 231 0.9× 270 1.3× 70 0.3× 30 0.3× 48 0.5× 37 564
J. Y. GAUTHIER Canada 11 240 0.9× 218 1.0× 109 0.5× 14 0.1× 118 1.3× 20 582

Countries citing papers authored by Frank Navas

Since Specialization
Citations

This map shows the geographic impact of Frank Navas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank Navas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank Navas more than expected).

Fields of papers citing papers by Frank Navas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frank Navas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank Navas. The network helps show where Frank Navas may publish in the future.

Co-authorship network of co-authors of Frank Navas

This figure shows the co-authorship network connecting the top 25 collaborators of Frank Navas. A scholar is included among the top collaborators of Frank Navas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frank Navas. Frank Navas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liang, Xiaofei, et al.. (2016). A Scalable Synthesis of the Difluoromethyl-allo-threonyl Hydroxamate-Based LpxC Inhibitor LPC-058. The Journal of Organic Chemistry. 81(10). 4393–4398. 14 indexed citations
2.
Shore, Derek M., Gemma L. Baillie, Dow P. Hurst, et al.. (2013). Allosteric Modulation of a Cannabinoid G Protein-coupled Receptor. Journal of Biological Chemistry. 289(9). 5828–5845. 62 indexed citations
3.
4.
Caravella, Justin A., Lihong Chen, Katrina L. Creech, et al.. (2011). Conformationally constrained farnesoid X receptor (FXR) agonists: Alternative replacements of the stilbene. Bioorganic & Medicinal Chemistry Letters. 21(20). 6154–6160. 28 indexed citations
5.
Bass, Jonathan Y., Justin A. Caravella, Lihong Chen, et al.. (2010). Conformationally constrained farnesoid X receptor (FXR) agonists: Heteroaryl replacements of the naphthalene. Bioorganic & Medicinal Chemistry Letters. 21(4). 1206–1213. 53 indexed citations
6.
Bass, Jonathan Y., Richard D. Caldwell, Justin A. Caravella, et al.. (2009). FXR agonist activity of conformationally constrained analogs of GW 4064. Bioorganic & Medicinal Chemistry Letters. 19(16). 4733–4739. 56 indexed citations
7.
Bass, Jonathan Y., Richard D. Caldwell, Justin A. Caravella, et al.. (2008). Conformationally constrained farnesoid X receptor (FXR) agonists: Naphthoic acid-based analogs of GW 4064. Bioorganic & Medicinal Chemistry Letters. 18(15). 4339–4343. 118 indexed citations
8.
Fang, Jing, Jonathan Britton, Frank Navas, et al.. (2008). Synthesis of 3-alkyl naphthalenes as novel estrogen receptor ligands. Bioorganic & Medicinal Chemistry Letters. 18(18). 5075–5077. 25 indexed citations
9.
Speake, Jason D., Frank Navas, Michael J. Bishop, et al.. (2003). 2-(Anilinomethyl)imidazolines as α1 adrenergic receptor agonists: α1a subtype selective 2′-heteroaryl compounds. Bioorganic & Medicinal Chemistry Letters. 13(6). 1183–1186. 15 indexed citations
10.
Bigham, Eric C., James A. Liacos, Frank Navas, et al.. (2002). α1-Adrenoceptor activation: A comparison of 4-(Anilinomethyl)imidazoles and 4-(Phenoxymethyl)imidazoles to related 2-imidazolines. Bioorganic & Medicinal Chemistry Letters. 12(23). 3449–3452. 4 indexed citations
11.
Bishop, Michael J., Judd Berman, Eric C. Bigham, et al.. (2002). α1-Adrenoceptor Agonists: The Identification of Novel α1A Subtype Selective 2′-Heteroaryl-2-(phenoxymethyl)imidazolines. Bioorganic & Medicinal Chemistry Letters. 12(3). 471–475. 17 indexed citations
12.
Navas, Frank, Michael J. Bishop, Jason D. Speake, et al.. (2002). 2-(Anilinomethyl)imidazolines as α1A Adrenergic Receptor Agonists: 2′-Heteroaryl and 2′-Oxime Ether Series. Bioorganic & Medicinal Chemistry Letters. 12(4). 575–579. 9 indexed citations
13.
Bishop, Michael J., Jason D. Speake, Frank Navas, et al.. (2002). 2-(Anilinomethyl)imidazolines as α1 Adrenergic Receptor Agonists:  the Discovery of α1a Subtype Selective 2‘-Alkylsulfonyl-Substituted Analogues. Journal of Medicinal Chemistry. 45(11). 2229–2239. 24 indexed citations
14.
Bishop, Michael J., Judd Berman, Eric C. Bigham, et al.. (2001). 2-(Anilinomethyl)imidazolines as α1-adrenoceptor agonists: the identification of α1A subtype selective 2′-carboxylic acid esters and amides. Bioorganic & Medicinal Chemistry Letters. 11(21). 2871–2874. 5 indexed citations
15.
Navas, Frank, Flora Tang, Lee T. Schaller, & Mark H. Norman. (1998). Analogues of the potential antipsychotic agent 1192U90: amide modifications. Bioorganic & Medicinal Chemistry. 6(6). 811–823. 5 indexed citations
16.
Navas, Frank & Mark H. Norman. (1996). The Design and Synthesis of a Hapten for 1192U90, a Potential Atypical Antipsychotic Agent. Synthetic Communications. 26(7). 1411–1421.
17.
Norman, Mark H., Greg C. Rigdon, William R. Hall, & Frank Navas. (1996). Structure−Activity Relationships of a Series of Substituted Benzamides:  Potent D2/5-HT2 Antagonists and 5-HT1a Agonists as Neuroleptic Agents. Journal of Medicinal Chemistry. 39(5). 1172–1188. 27 indexed citations
18.
Norman, Mark H., Frank Navas, James B. Thompson, & Greg C. Rigdon. (1996). Synthesis and Evaluation of Heterocyclic Carboxamides as Potential Antipsychotic Agents. Journal of Medicinal Chemistry. 39(24). 4692–4703. 42 indexed citations
19.
Norman, Mark H., Greg C. Rigdon, William R. Hall, & Frank Navas. (1996). ChemInform Abstract: Structure‐Activity Relationships of a Series of Substituted Benzamides: Potent D2/5‐HT2 Antagonists and 5‐HT1a Agonists as Neuroleptic Agents.. ChemInform. 27(27). 3 indexed citations
20.
Norman, Mark H., Greg C. Rigdon, Frank Navas, & Barrett R. Cooper. (1994). Cyclic Benzamides as Mixed Dopamine D2/Serotonin 5-HT2 Receptor Antagonists: Potential Atypical Antipsychotic Agents. Journal of Medicinal Chemistry. 37(16). 2552–2563. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paul K. Spearing Breakdown of academic impact, for papers by Xiao‐Hui Gu Breakdown of academic impact, for papers by Charles D. Thompson Breakdown of academic impact, for papers by Emiliano Rosatelli Breakdown of academic impact, for papers by Feroze Ujjainwalla Breakdown of academic impact, for papers by Lamees Hegazy Breakdown of academic impact, for papers by Fumihiko Akahoshi Breakdown of academic impact, for papers by Kenneth A. Koeplinger Breakdown of academic impact, for papers by Hea‐Young Park Choo Breakdown of academic impact, for papers by J. Y. GAUTHIER
Rankless by CCL
2026